ABSTRACT
SOURCE CITATION: Chaudhuri D, Nei AM, Rochwerg B, et al. 2024 focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia. Crit Care Med. 2024;52:e219-e233. 38240492.
Subject(s)
Adrenal Cortex Hormones , Community-Acquired Infections , Respiratory Distress Syndrome , Sepsis , Humans , Respiratory Distress Syndrome/drug therapy , Sepsis/drug therapy , Adrenal Cortex Hormones/therapeutic use , Community-Acquired Infections/drug therapy , Pneumonia/drug therapy , AdultABSTRACT
This JAMA Insights discusses the symptoms, diagnosis, and treatment of chronic thromboembolic pulmonary hypertension.
Subject(s)
Hypertension, Pulmonary , Pulmonary Embolism , Thromboembolism , Humans , Chronic Disease , Endarterectomy , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/surgery , Hypertension, Pulmonary/therapy , Pulmonary Embolism/diagnosis , Pulmonary Embolism/etiology , Pulmonary Embolism/surgery , Pulmonary Embolism/therapy , Thromboembolism/complications , Thromboembolism/diagnosis , Thromboembolism/surgery , Thromboembolism/therapyABSTRACT
SOURCE CITATION: Corren J, Menzies-Gow A, Chupp G, et al. Efficacy of tezepelumab in severe, uncontrolled asthma: pooled analysis of the PATHWAY and NAVIGATOR clinical trials. Am J Respir Crit Care Med. 2023;208:13-24. 37015033.
Subject(s)
Asthma , Humans , Asthma/drug therapy , Antibodies, Monoclonal, Humanized/therapeutic use , InflammationABSTRACT
SOURCE CITATION: Bhatt SP, Rabe KF, Hanania NA, et al; BOREAS Investigators. Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts. N Engl J Med. 2023;389;205-214.37272521.
Subject(s)
Bronchodilator Agents , Pulmonary Disease, Chronic Obstructive , Humans , Administration, Inhalation , Pulmonary Disease, Chronic Obstructive/drug therapy , InflammationABSTRACT
SOURCE CITATION: Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388:1478-1490. 36877098.
